iScience (Sep 2019)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress

  • Zaoke He,
  • Shixiang Wang,
  • Yuanyuan Shao,
  • Jing Zhang,
  • Xiaolin Wu,
  • Yuxing Chen,
  • Junhao Hu,
  • Feng Zhang,
  • Xue-Song Liu

Journal volume & issue
Vol. 19
pp. 256 – 266

Abstract

Read online

Summary: How cells adapt to oncogenic transformation-associated cellular stress and become fully transformed is still unknown. Here we identified a novel GGCT-regulated glutathione (GSH)-reactive oxygen species (ROS) metabolic pathway in oncogenic stress alleviation. We identified GGCT as a target of oncogenic Ras and that it is required for oncogenic Ras-induced primary mouse cell proliferation and transformation and in vivo lung cancer formation in the LSL-Kras G12D mouse model. However, GGCT deficiency is compatible with normal mouse development, suggesting that GGCT can be a cancer-specific therapeutic target. Genetically amplified GGCT locus further supports the oncogenic driving function of GGCT. In summary, our study not only identifies an oncogenic function of GGCT but also identifies a novel regulator of GSH metabolism, with implications for further understanding of oncogenic stress and cancer treatment. : Biological Sciences; Cell Biology; Cancer Subject Areas: Biological Sciences, Cell Biology, Cancer